Intriguingly, though it demonstrates context-dependent functions across tumor types, it exhibits tumor-suppressive activity in breast cancer [27] but promotes angiogenesis and tumor progression in hepatocellular carcinoma by regulating the HIF1α/VEGF/NF-κB signaling axis [20]. This evidence concerns the gene VEGFA and breast cancer.